rs2073617
| Orientation | minus |
| Stabilized | minus |
| Geno | Mag | Summary |
|---|---|---|
| (C;C) | 0 | common in clinvar |
| Make rs2073617(C;T) |
| Make rs2073617(T;T) |
| Reference | GRCh38.p2 38.2/144 |
| Chromosome | 8 |
| Position | 118952044 |
| Gene | COLEC10, TNFRSF11B |
| is a | snp |
| is | mentioned by |
| dbSNP | rs2073617 |
| dbSNP (classic) | rs2073617 |
| ClinGen | rs2073617 |
| ebi | rs2073617 |
| HLI | rs2073617 |
| Exac | rs2073617 |
| Gnomad | rs2073617 |
| Varsome | rs2073617 |
| LitVar | rs2073617 |
| Map | rs2073617 |
| PheGenI | rs2073617 |
| Biobank | rs2073617 |
| 1000 genomes | rs2073617 |
| hgdp | rs2073617 |
| ensembl | rs2073617 |
| geneview | rs2073617 |
| scholar | rs2073617 |
| rs2073617 | |
| pharmgkb | rs2073617 |
| gwascentral | rs2073617 |
| openSNP | rs2073617 |
| 23andMe | rs2073617 |
| SNPshot | rs2073617 |
| SNPdbe | rs2073617 |
| MSV3d | rs2073617 |
| GWAS Ctlg | rs2073617 |
| Max Magnitude | 0 |
| ? | (C;C) (C;T) (T;T) | 28 |
|---|---|---|
|
| ||
[PMID 26065000
] Osteoprotegerin Polymorphisms in a Mexican Population with Rheumatoid Arthritis and Generalized Osteoporosis: A Preliminary Report
[PMID 28244588] Investigation of OPG/RANK/RANKL Genes as a Genetic Marker for Cardiac abnormalities in Thalassemia Major Patients.
| ClinVar | |
|---|---|
| Risk | rs2073617(T;T) |
| Alt | rs2073617(T;T) |
| Reference | Rs2073617(C;C) |
| Significance | Non-pathogenic |
| Disease | Hyperphosphatasemia with bone disease |
| Variation | info |
| Gene | TNFRSF11B COLEC10 |
| CLNDBN | Hyperphosphatasemia with bone disease |
| Reversed | 1 |
| HGVS | NC_000008.10:g.119964283G>A |
| CLNSRC | |
| CLNACC | RCV000404609.1, |
[PMID 28824302
] Association of Genes Variants in RANKL/RANK/OPG Signaling Pathway with the Development of Osteonecrosis of the Femoral Head in Chinese Population.
[PMID 30309792] Association of SNP-SNP Interactions Between RANKL, OPG, CHI3L1, and VDR Genes With Breast Cancer Risk in Egyptian Women.
[PMID 31658533] [Association between TNFRSF11A and TNFRSF11B gene polymorphisms and the outcome of hepatitis C virus infection].
